Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,713 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 686
Recruiting: 382
Ph III recruiting: 46
Growth YoY: +5.3%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (278)

clinicaltrialsPublishedShowing 451–500 of 778 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07421141	De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer(Opti-HER2)	active not recruiting	Phase 2	186	National Medical Research Radiological Centre of the Ministry of Health of RussiaOTHER	1	Feb 27, 2026	clinicaltrials
NCT07377643	IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer	recruiting	Phase 3	540	Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.